Assuming somebody at LexBio reads this board is a relevant question. These days, not reading social media would be considered incompetent. So, let's assume they do. Fact is, there aren't many boards which talk so much about LexBio. Unless I haven't found it, which is possible, this is the most active one.
So, here's a thought for LexBio who, according to the stock email responses some of you have received, is asking for advice and ideas. If LexBio needs to sell the patent of HeartSentry because they don't have the smarts or hiring power to get the people who would know what to do with it, then sell it for stock of the company who buys it. That way, the financial power of HeartSentry's potential earnings is passed on to current shareholders.
At least make it half cash and half stock. But true insult would be surrendering the HeartSentry patent, thereby getting no part of the potential success of it. After all, the only thing LexBio has going for it is the future financial potential of the HeartSentry. Zero revenue and no plan for monetizing HeartSentry is why the SP is what it is in the first place.
On the other hand, if at the end of this debacle LexBio ends up bankrupt and the HeartSentry patent ends up under the ownership of one of their cousin companies which have been mentioned before on this board, then there will need to be trouble for then we will know the entire thing has been a sham. Or other shams involving the patent going to a group differently affiliated with the current patent owners.
I genuinely hope this has not been a sham for that is what gives capitalism a bad name.
